InflaTMP: Design of a novel combination anti-inflammatory and anti-viral biotherapeutic for COVID-19 targeting the NLRP3 inflammasome and TMPRSS2

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/04/21 → 31/03/23